enow.com Web Search

  1. Ads

    related to: rheumatoid arthritis fda approved drugs

Search results

  1. Results from the WOW.Com Content Network
  2. Adalimumab - Wikipedia

    en.wikipedia.org/wiki/Adalimumab

    Adalimumab, sold under the brand name Humira and others, is a disease-modifying antirheumatic drug and monoclonal antibody used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis.

  3. Tofacitinib - Wikipedia

    en.wikipedia.org/wiki/Tofacitinib

    In November 2012, the FDA approved tofacitinib to treat adults with moderately to severely active rheumatoid arthritis who have had an inadequate response to, or who are intolerant of, methotrexate. [20] The FDA approved only the five-mg, twice-daily dose on the grounds that a higher dose was not considered to have an adequate risk-to-benefit ...

  4. List of therapeutic monoclonal antibodies - Wikipedia

    en.wikipedia.org/wiki/List_of_therapeutic...

    This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.

  5. FDA Approves Expanded Indication for ACTEMRA® in Rheumatoid ...

    www.aol.com/2012/10/12/fda-approves-expanded...

    FDA Approves Expanded Indication for ACTEMRA ® in Rheumatoid Arthritis SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Genentech, Inc., a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY ...

  6. Baricitinib - Wikipedia

    en.wikipedia.org/wiki/Baricitinib

    Despite widespread expectations that the FDA would approve baricitinib for rheumatoid arthritis, [24] in April 2017, the FDA issued a rejection, citing concerns about dosing and safety. [25] [26] In May 2018, baricitinib was approved in the United States for the treatment of rheumatoid arthritis. [9] [12] [10] In March 2020, the US FDA granted ...

  7. Rofecoxib - Wikipedia

    en.wikipedia.org/wiki/Rofecoxib

    Rofecoxib was approved by the FDA to treat osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, acute pain conditions, migraine, and dysmenorrhea. When it was marketed, it gained widespread acceptance among physicians treating patients with arthritis and other conditions causing chronic or acute pain. [1]

  1. Ads

    related to: rheumatoid arthritis fda approved drugs